396
Index
pharmacokinetics, 234–235, 236–245 phase I enzymes, 240–241, 242 phenobarbital, 166, 246
phenytoin, 7, 85, 125, 166–167, 222, 236, 237, 241, 242–243, 248–250 phosphate, dietary, 171 phosphate binders, 172
phosphorus, 12, 127, 171, 172, 175 drug interactions, 249 phosvitin, 161 physical activity, 10, 11 diabetes, 177, 180 skin condition and, 199 physical activity levels (PAL), 10–11 physical therapy, 44, 45 pioglitazone, 184 Pioneer Network, 31–32
Plan-Do-Study-Act (PDSA), 331, 332, 339 Planetree, 31, 32 Plan of Correction, 316 plate guard, 41
pneumonia, 149, 150, 151, 276, 281, 287 polydipsia, 177 polypharmacy, 109, 137, 235 dehydration and, 125
polyunsaturated fatty acids, 13 positioning, eating, 45 post-hospital syndrome, 288 potassium, 6, 12, 112, 127, 128–129, 173, 175, 218, 246–247
drug interactions, 239, 241, 249 lab tests, 225
potassium chloride, 148 poverty, 4, 5, 17, 22–23, 76, 86, 107, 137 PPN. See peripheral parenteral nutrition (PPN) Preadmission Screening and Resident Review Report (PASRR), 311, 315 prealbumin (PAB), 83, 217, 227, 230 predialysis clients, 172 Premier Research Database, 288 preparedness, 359, 360, 365, 368, 369–383 preparedness cycle, 360 pressor amines, 237–238
pressure ulcers, 34, 199–213, 287, 306 guidelines for care, 208 lab tests, 227
nutrient needs and, 76, 84, 209–210 Pressure Ulcer Scale for Healing (PUSH), 203, 211–213
primidone, 237, 246 problem, etiology, signs and symptoms. See PES (problem, etiology, signs and symptoms) prompt hierarchy, 42, 43
Prospective Payment System (PPS) assessments, 304, 322
protein, 6, 13, 76, 83, 98–100, 125, 172–173, 175, 179, 235, 237, 254 catabolism, 121, 219 drug interactions, 234, 249 laboratory screening, 216, 219, 227 pressure ulcers and, 199, 202, 209 requirements, 76, 87, 189, 257
protein-energy malnutrition, 9, 83, 137, 199, 220, 224, 225, 229 protein energy wasting (PEW), 170, 171 proton pump inhibitors, 7, 10–11 psychological factors, 86, 106, 171, 271 psychotropic drugs, 7, 306 PTH. See parathyroid hormone (PTH) Public Health Service Act, 338, 365 PUFA. See polyunsaturated fatty acids pulmonary system, 8, 83 PUSH. See Pressure Ulcer Scale for Healing (PUSH)
pyridoxine, 98–100, 248 drug interactions, 248
quadriplegics, 81
quality assurance, 321–332, 334, 335–336 Quality Assurance and Performance Improvement (QAPI), 326–332, 334–336 quality improvement, 326, 337–338 Quality Indicator Survey (QIS), 131, 308, 319– 320, 335
quality management, 56, 337 Quality Measure (QM) reports, 311
radiation, 156, 190, 260 radiation therapy, 85, 137, 188, 190–191, 196–197 RAI. See Resident Assessment Instrument (RAI) RDAs. See recommended dietary allowances (RDAs) RDIs. See reference daily intakes (RDIs) recommended dietary allowances (RDAs), 10, 12–13, 48, 192
red blood cells, 83, 159, 163, 172, 187, 199, 222–224
reference daily intakes (RDIs), 42, 254
Previous Page